Clinical Trials > Phase I/II Clinical Trials Products & Reviews

Spark Holland has been operating at the forefront of autosampler design for 25 years. Spark’s Reliance™ autosampler is the first true bio-injector, and is preferred by customers for 4 simple reasons: -   Lowest possible carry-over-   High-speed wash cycles-   Low maintenance-   Conditioned sample storage The Reliance™ autosampler complies with GLP requirements and can be coupled with most LC-MS systems. It runs fully integra…

As clinical trials generate growing volumes of complex data, turning insights into action is challenging. Signals Clinical, built on the Spotfire® analytics platform and enhanced with AI-powered analysis, helps clinical data review teams gain timely, governed insights to improve data quality, oversight, and patient safety.

Designed to deliver equivalent results across an entire network, the Atellica CI Analyzer brings the power and possibility of the central lab to spoke and STAT laboratories.

Intelligent Clinical is a Clinical Research Facility based in Glasgow, UK supporting phase II-IV clinical trials for pharmaceutical, nutraceutical, medical device, food and OTC products. Our experienced clinical team has a proven track record of meeting the requirements of any clinical trial. 

The Wieslab® Complement Pathway-specific Functional assays are well known within the complement world, used both as an alternative to hemolytic assays and a diagnostic tool for complement functional assessment. Based on the ELISA setup, the assays provide a robust and standardized assay platform, delivering fast, reliable, and easy-to-interpret results within 3 hours.

Moving quickly and safely through Phase I/IIa trials is critical to successful drug development.  The QPS Phase I research facilities feature more than 550 beds across six strategically located facilities on three continents. QPS is well known for its success in first-in-human clinical trials. All Phase I sites are staffed by expert clinical pharmacology teams that routinely conduct hundreds of phase I/IIa studies annually.